Medication info
Telmisartan and Amlodipine Combination Tablets 40/10 mg (Telmisartan, Amlodipine Besilate)

Telmisartan and Amlodipine Combination Tablets 40/10 mg (Telmisartan, Amlodipine Besilate)

Prescription medicationOral
Ingredient · strength
Telmisartan›40mgAmlodipine Besylate›13.87mg
Manufacturer / importer
Green Cross Corp.
Appearance
White and light blue double-convex oval shape tablet
Packaging
30 tablets (10 tablets/PTP X3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201606795 · Approved 2016.11.29 · Insurance code 698003340

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section “3. Patients Requiring Caution”). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; its use is not recommended.

Ingredients

Manufacturer
Green Cross Corp.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Used in patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy with Telmisartan or Amlodipine.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section “3. Patients Requiring Caution”). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; its use is not recommended.

Precautions

This medication can pose a serious risk to the fetus, especially during the second and third trimesters of pregnancy, and should not be taken by pregnant women or those who could become pregnant. This medication should not be used in patients with certain diseases, such as severe liver or heart problems, severe hypotension, and those with allergies to specific medications. Patients with impaired liver or kidney function should use this medication with caution, and a dosage adjustment may be necessary. When taking this medication, side effects such as dizziness or edema may occur, so consult your physician if any abnormal symptoms arise. Blood pressure may drop too low, so blood pressure and symptoms should be closely monitored, particularly at the beginning of treatment. This medication may interact with other drugs, so if you are taking other medications, be sure to inform your physician or pharmacist. Caution is especially required when taking potassium supplements or consuming potassium-rich foods, as there is a risk of increased potassium levels. It is advisable not to take this medication while breastfeeding, and dose adjustments and caution are necessary when administering it to children or the elderly. In case of overdose, severe hypotension or heart problems may occur, necessitating immediate medical attention. The safety and efficacy of this medication has not been sufficiently established in children and its use is not recommended. While taking the medication, be cautious when driving or operating hazardous machinery, as dizziness or drowsiness may occur.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • sensory abnormalities
  • sensory loss
  • taste disturbances
  • trembling
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver impairment
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • increased urinary frequency
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • elevated blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that protects it from light, as it is sensitive to light. Additionally, it is important to store the medication at room temperature, between 1°C and 30°C, to maintain its effectiveness.

Appearance and packaging

Appearance

White and light blue double-convex oval shape tablet

Package unit

30 tablets (10 tablets/PTP X3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.